Next, we tested the expression of NTRK2 (neurotrophic receptor tyrosine kinase 2, TrkB) and BCL2 (B cell CLL/lymphoma 2); both genes linked to neural differentiation whose expression is increased in RA-treated neuroblastoma cells [34, 46, 57–60]. Here, BCL2 is linked to neuroblastoma.